Neumora Therapeutics Announces Initiation of Phase 1 Clinical Study Neumora Therapeutics, Inc. has initiated a Phase 1 clinical study of NMRA-898, a M4 Positive Allosteric Modulator.
Isuzu FA Trophy Second Round Proper Draw Confirmed The draw for the Isuzu FA Trophy Second Round Proper has been confirmed, with 40 ties s…
Kymera Therapeutics Presents New Preclinical Data for KT-579 Kymera Therapeutics, Inc. announced the presentation of new preclinical data …
Councils' Role in New Towns Success Peers have emphasized the importance of councils in making the New Towns programme a success. A…
Rolex 24 Grid Expansion Not Possible Due to Pit Lane Space IMSA President John Doonan stated that expanding the Rolex 24 grid is currently…
Vesper Solar 600 MW Texas Project The Vesper Solar 600 MW Texas project demonstrates how an agrivoltaics mindset can unlock prime sites fo…
ASX Market Update The Australian stock market is experiencing a decline, led by significant losses in the healthcare and tech sectors, des…
Scientists Say This 5-Minute Trick Could Help You Live Longer New research suggests it could be the key to boosting heart and lung health.…
A Studio With a Heated Solarium on West 14th for $780,000 For under a million dollars, various housing configurations are available, inclu…
Senator Questions 946 Infra Projects SENATE Finance Committee Chair Senator Sherwin T. Gatchalian said about 946 projects worth P14.4 bill…
Introduction to Circuit Design with Capacitors Among the abundance of components making up electronic circuits, very few are as important …